Visit B. Braun OEM at ICSE 2015. Themed by “We are with you right from the start“ we will walk you through our service portfolio from offering products for your clinical trial to successful market launch of your product.
Visit B. Braun OEM at ICSE 2015. Themed by “We are with you right from the start“ we will walk you through our service portfolio from offering products for your clinical trial to successful market launch of your product.
B. Braun OEM Division. Tailor-made solutions for the healthcare industryExpertise in contract manufacturing and infusion therapy products
B. Braun supplies healthcare markets worldwide and is employing approx. 54,000 individuals.
The company is currently represented in more than 62 countries worldwide and the portfolio comprises more than 120,000 pharmaceutical and medical articles.
B. Braun OEM offers standard products or customized versions. Even the standard range contains hundreds of product versions, with which countless applications can be implemented.
Standard products
OEM is specialized in developing customer-specific solutions for you. Most of our products can be individually adapted to your requirements.
Customized products and services
We look forward to meeting you at our booth 1D21!
B. Braun Melsungen AG
OEM Division Europe
Carl-Braun-Strasse 1
34212 Melsungen
Germany
Phone: +49 5661 71-0
Fax: +49 5661 71-3562
info-europe@bbraunoem.com
http://www.bbraunoem.comwww.kitpacking-bbraun.com
Diving Deep into Carrier-Based Formulation and Process Optimization
December 23rd 2024Carrier-based formulations for dry powder inhalers are carefully designed to transport extremely small particles into the lungs. Jet milling can be used to micronize these particles, with both high and low shear mixing processes used to formulate mixtures capable of carrying the fine API particles into the deep lung. This paper looks at the requirements for pulmonary delivery via carrier-based inhaled powder formulations, and how jet milling can be used to manufacture effective and stable materials for these formulations
Molecular Properties of PROTACs and the Relationship to Formulation Design
December 20th 2024Analyzation of a diverse set of PROTAC (Proteolysis Targeting Chimeras – a class of TPDs) structures and their calculated properties, identifying key structure-property trends that contribute to low oral bioavailability.